Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=pymx.obLatest Financial News for POLYMEDIX INCen-usMon, 21 Dec 2009 21:29:21 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091221/pymx.ob8-k.htmlyahoo_finance/3530515958Mon, 21 Dec 2009 21:29:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091218/20091218005098.html?.v=1RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, has successfully completed the first two segments of a Phase 1B clinical safety study with its novel antibiotic drug candidate PMX-30063.yahoo_finance/140965839Fri, 18 Dec 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091209/20091209005970.html?.v=1RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, will host a webcast event on Heparin, Bleeding Complications, and PolyMedix’s PMX-60056 Heparin Reversing Agent on Tuesday, December 15, 2009 at 10:00 am EST.yahoo_finance/1981237124Wed, 9 Dec 2009 17:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091207/20091207005027.html?.v=1RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced that data will be presented on its heptagonist compounds at the annual meeting of the American Society of Hematology in New Orleans, Louisiana.yahoo_finance/719897997Mon, 7 Dec 2009 13:31:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=pymx.obyahoo_finance/4225795835Fri, 20 Nov 2009 18:04:46 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091117/sf13113.html?.v=1Merriman Curhan Ford Group, Inc. acted as lead placement agent in PolyMedix Inc.'s $20.7 million registered public offering of 20.7 million units. The units, which were priced at $1.00 per unit, consist of one share of PolyMedix common stock and one five year warrant to purchase 0.30 of a share of PolyMedix common stock at $1.25 per share.yahoo_finance/976439464Tue, 17 Nov 2009 21:25:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091117/pymx.ob8-k.htmlyahoo_finance/3706817114Tue, 17 Nov 2009 21:00:42 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kughsfc/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/11/16/daily20.html?ana=yfcpcyahoo_finance/2856076170Tue, 17 Nov 2009 17:05:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091117/20091117005939.html?.v=1RADNOR, Pa.----PolyMedix Inc. , an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.yahoo_finance/2716967849Tue, 17 Nov 2009 14:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/pymx.ob8-k.htmlyahoo_finance/3558030943Thu, 12 Nov 2009 21:19:38 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178205.html?.v=1yahoo_finance/77452893Thu, 12 Nov 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12keblm4o/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/11/09/daily22.html?ana=yfcpcyahoo_finance/565130841Wed, 11 Nov 2009 16:05:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091111/20091111005614.html?.v=1RADNOR, Pa.----PolyMedix Inc. , an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today the pricing of a registered public offering of up to 21,000,000 units consisting of shares and warrants for $1.00 per unit, or a total of up to $21 million in gross proceeds.yahoo_finance/2709231749Wed, 11 Nov 2009 14:25:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091028/pymx.ob8-k.htmlyahoo_finance/1677257457Wed, 28 Oct 2009 17:09:10 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091027/20091027005453.html?.v=1RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders, has completed a second successful clinical study of its anticoagulant reversing agent, PMX-60056.yahoo_finance/1465318308Tue, 27 Oct 2009 11:31:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090929/20090929006025.html?.v=1RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a second clinical trial, a Phase 1B pilot proof of concept study, in the U.S. with its anticoagulant reversing agent PMX-60056 under an Investigational New Drug application filed with the U.S.yahoo_finance/64952486Tue, 29 Sep 2009 15:17:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090928/20090928005518.html?.v=1RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, “Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers.”yahoo_finance/2662710092Mon, 28 Sep 2009 12:26:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090706/pymx.ob8-k.htmlyahoo_finance/4124418077Mon, 6 Jul 2009 17:46:50 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090630/pymx.ob8-k.htmlyahoo_finance/1787058007Tue, 30 Jun 2009 19:42:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090522/pymx.ob8-k.htmlyahoo_finance/598245813Fri, 22 May 2009 14:24:31 Etc/GMT